Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Resear...
Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the edit...
Bionano Genomics Inc. ("Bionano" or the "Company") (NASDAQ:BNGO) today announced that it has completed a privat...
Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for ce...
BTIG analyst Mark Massaro maintains Bionano Genomics (NASDAQ:BNGO) with a Buy and lowers the price target from $3 to $2.
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0....
Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at Univer...
